| Title |
Cannabinoids in the Treatment of Epilepsy: Current Status and Future Prospects
|
|---|---|
| Published in |
Neuropsychiatric Disease and Treatment, February 2020
|
| DOI | 10.2147/ndt.s203782 |
| Pubmed ID | |
| Authors |
Alessandra Morano, Martina Fanella, Mariarita Albini, Pierangelo Cifelli, Eleonora Palma, Anna Teresa Giallonardo, Carlo Di Bonaventura |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 33% |
| Japan | 1 | 11% |
| New Zealand | 1 | 11% |
| Czechia | 1 | 11% |
| Unknown | 3 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 89% |
| Practitioners (doctors, other healthcare professionals) | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 195 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 195 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 34 | 17% |
| Student > Master | 22 | 11% |
| Student > Ph. D. Student | 18 | 9% |
| Researcher | 11 | 6% |
| Other | 10 | 5% |
| Other | 18 | 9% |
| Unknown | 82 | 42% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 32 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 24 | 12% |
| Biochemistry, Genetics and Molecular Biology | 13 | 7% |
| Agricultural and Biological Sciences | 11 | 6% |
| Neuroscience | 10 | 5% |
| Other | 23 | 12% |
| Unknown | 82 | 42% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2024.
All research outputs
#1,588,956
of 25,619,480 outputs
Outputs from Neuropsychiatric Disease and Treatment
#202
of 3,139 outputs
Outputs of similar age
#39,236
of 475,657 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#6
of 80 outputs
Altmetric has tracked 25,619,480 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,139 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 475,657 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 93% of its contemporaries.